Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Southern Danish University | UNKNOWN |
| Herrens Mark A/S | UNKNOWN |
| Natur Drogeriet A/S | UNKNOWN |
| Future Food Innovation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Previous literature has shown that the molecular form of isoflavones (as aglycones or glycosides) and food matrices can influence the bioavailability of these compounds in humans and hence their efficacy. To determine the effects of processing and food matrices on the bioavailability of active compounds derived from red clover the investigators will execute a 5 phase, cross-over design, open label, RCT using 20 healthy women aged between 18 to 40 years. Participants will receive 5 different formulations of red clover and bioavailability will be monitored in blood plasma using LC-MS.
The aim of this study is to elucidate the effects food matrices and processing on the bioavailability of active compounds on the bioavailability of red clover derived isoflavones. 20 healthy participants will receive red clover derived isoflavones in five different formulations. The five formulations are split up into five phases:
Phase 1) Fermented extract in liquid form Phase 2) Fermented extract (freeze-dried) in capsule form Phase 3) Fermented extract (freeze-dried) in tablet form Phase 4) Fermented extract (concentrated) mixed in yogurt Phase 5) Un-fermented red clover in capsule or tablet form The trial will last 5-6 weeks for each participant. Plasma sample collection will take place both pre-and post- ingestion of a formulation, participants will receive blood tests at intervals -15 min, 0 min, 2hr, 4hr, 6hr, 8hr and 12hr (on the day of ingestion) and on the subsequent two mornings (24hr and 48hr) following the initiation of a phase. There will be a minimum. 5 day intervals between all phases (washout periods). Isoflavones biochanin A, formononetin, genistein and daidzein present in plasma will be detected using HPLC-MS for each phase, thus creating a bioavailability curve that can be compared to each of the other phases. The primary endpoint is to determine whether fermented extract is more bioavailable than unfermented extract.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Capsule (aglycone) | Active Comparator | single bolus 40mg isoflavone formulation of fermented extract in freeze-dried capsule. Fermented red clover isoflavones in aglycone form |
|
| Tablet (aglycone) | Active Comparator | single bolus 40mg isoflavone aglycone formulation of fermented extract in freeze-dried tablet. Fermented red clover isoflavones in aglycone form |
|
| Yoghurt (aglycone) | Active Comparator | single bolus 40mg isoflavone aglycone formulation of fermented extract mixed with yoghurt Fermented red clover isoflavones in aglycone form |
|
| Liquid extract (aglycone) | Active Comparator | single bolus 40mg isoflavone aglycone formulation of fermented extract in liquid Fermented red clover isoflavones in aglycone form |
|
| Tablet unfermented (glycoside) | Active Comparator | single bolus 40mg isoflavone aglycone equivalent tablet formulation of unfermented red clover isoflavones Unfermented glycosides (as aglycone equivalents) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fermented red clover isoflavones in aglycone form | Dietary Supplement | Fermented isoflavones in aglycone form |
|
| Measure | Description | Time Frame |
|---|---|---|
| Bioavailability of isoflavones in terms of fermented vs unfermented formulations | As measured by iAUC plasma concentrations of isoflavones over 48 hours | -15min, 0hr, 2hr, 4hr, 6hr, 8hr, 12hr, 24hr, 48hr |
| Measure | Description | Time Frame |
|---|---|---|
| Bioavailability of isoflavones in terms of matrices (tablet, capsule, yoghurt and liquid) | As measured by iAUC plasma concentrations of isoflavones over 48 hours | -15min, 0hr, 2hr, 4hr, 6hr, 8hr, 12hr, 24hr, 48hr |
Not provided
Inclusion criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Per B Jeppesen, Prof. PhD | University of Aarhus | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University Hospital | Aarhus | Central Jutland | 8000 | Denmark |
Not provided
| INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Unfermented glycosides (as aglycone equivalents) | Dietary Supplement | Unfermented aglycone equivalents in glycoside form |
|